Young adults aged 18 to 24 years old who regularly consume cannabis or who consume cannabis daily.
.
The addiction psychiatry research unit (APRU), directed by Dr Didier Jutras-Aswad, head of the psychiatry department of the CHUM and clinical researcher, is conducting a dynamic clinical research program focused on psychoactive substances, mental health and drug addiction. This unit is made up of a multidisciplinary team, trained to the highest standards in clinical research. The team includes a researcher, a project manager, research coordinators, research assistants, scientific writers and graduate students.
In Search of a Remedy for Use Disorder of Amphetamines: How Close Are We? Amphetamine use disorder is emerging as a silent public health problem claiming more lives in 2020s than ever before in Canada
My experience with OPTIMA – I found it very interesting, then I found it very pleasant. The staff have always been very kind, welcoming and polite. It allowed me to be able to take responsibility for my problem, to solve it without having to go through difficult things. I was able to keep my job, and it was very important for me to be able to keep my job and to have access to treatment as easily as possible. And at the same time, it’s nice to be able to answer your questions and if it can help other people in the future who are in the same situation as me, well it’s nice.
participated in:OPTIMA Study
CHUM Research Center (CRCHUM)
900 St-Denis St., 4th & 5th floor,
Montreal (QC) H2X0A9
Phone: 514-890-8000 #30933
Email: labo.jutras.aswad@gmail.com
To contact the media relations team: andree-anne.toussaint.chum@ssss.gouv.qc.ca
Myths and realities of a clinical research study
*People wishing to participate in one of the studies or who have questions about them can contact the lab. People who wish to obtain addiction and/or mental health care or services can contact the addiction rehabilitation center or the psychosocial center in their region. They can also call emergency services if their condition requires it.